From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma
Children’s Oncology Group study shows benefit for children and adolescents with high-risk HL...
Read MoreChildren’s Oncology Group study shows benefit for children and adolescents with high-risk HL...
Read MoreDec 6, 2019 | All Articles, Cancer, Children and Teens, Health, News | 0 |
Access to Clinical Trials May Drive Differences in Outcome Among Childhood Hodgkin Lymphoma...
Read More